The longitudinal follow-up the dynamics of tumor marker CYFRA 21-1 establish a fact of local relapse in primary NSCLC (36 months follow-up study on 500 patients) (CROSBI ID 573171)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Pavićević, Radomir ; Bubanović, Gordana ; Krajna, Ana, Miličić, Jasna
engleski
The longitudinal follow-up the dynamics of tumor marker CYFRA 21-1 establish a fact of local relapse in primary NSCLC (36 months follow-up study on 500 patients)
The clinical application of cytokeratin marker CYFRA 21-1 was standardized on 3000 patients. In all patients the start value of CYFRA 21-1 was determined before therapy (Electrochemiluminescence method, Roche Diagnostics). Tumor marker CYFRA 21-1 was assessed longitudinally 1 to36 months after the therapy...
CYFRA 21-1; lung cancer; local relapse
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
121-121.
2001.
objavljeno
Podaci o matičnoj publikaciji
The Second European-American intensive course in clinical and forensic genetics
Podaci o skupu
The Second European-American Intensive Course in Clinical and Forensic Genetics
poster
01.09.2001-14.09.2001
Dubrovnik, Hrvatska
